Company profile
Verily Life Sciences LLC
Verily Life Sciences LLC has 3 AI-enabled medical devices on the FDA list. The first decision was on January 17, 2019 and the most recent on July 19, 2022 (Study Watch with Irregular Pulse Monitor (Home), Study Watch with Irregular Pulse Monitor). Its most common review panel is Cardiovascular (3 devices).
3AI devices
2019First decision
2022Latest decision
1Specialties
Per year
201920202022
By specialty
Related guides
Timeline
- Study Watch with Irregular Pulse Monitor (Home), Study Watch with Irregular Pulse Monitor · Cardiovascular · DXH
- Study Watch with Irregular Pulse Monitor · Cardiovascular · DXH
- Study Watch · Cardiovascular · DXH